The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021). For more details : https://www.marketsandmarkets.com/Market-Reports/western-blotting-market-235810711.html

1. Western Blotting Market and the Increasing Demand
for Personalized Medicine
According to the new market research report "Western Blotting Market by Product (Instruments,
Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User
(Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to
2021",published by MarketsandMarkets™,The western blotting market is projected to reach USD 730.7
Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to
2021).
Browse in-depth TOC on “Western Blotting Market"
132 - Table
41 – Figures
169 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711
In the coming years, the western blotting market is expected to witness the highest growth in the Asia-
Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology
industry in China, government initiatives supported by funding in Japan, growing funding for agriculture
research in India, increasing diagnosis and related funding in Australia, and growing prevalence of
herpes simplex virus (HSV) in southeast Asia.
New product launches was the major growth strategy adopted by players in the western blotting market.
The western blotting market is dominated by Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific,
Inc. (U.S.), and GE Healthcare (U.S.).
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711
These players jointly accounted for approximately 80% of the market in 2016. Other players having
significant presence in this market include Advasta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer,
Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd.

2. (Switzerland), and Cell Signaling Technology, Inc. (U.S.).).
Bio-Rad Laboratories, Inc. is the leading player in the western blotting market. The company is a leading
manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex
biological and chemical materials. The company serves the fields of life science research, healthcare, and
analytical chemistry with its innovative products and services. The company’s leading position in the
market can be attributed to its wide customer base.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711